Zhuoxian Cao

机构：University of Science and Technology of China, Guangdong Pharmaceutical University, National Center for Drug Screening, Southern Medical University

发表论文 13 篇 · 总被引 442 次 · h-index 8

代表论文

• SIRT3‐dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth (2023 · EMBO Reports · 被引 234)
• Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6 (2021 · ACS Chemical Biology · 被引 64)
• Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer (2021 · Journal of Medicinal Chemistry · 被引 57)
• Direct C(sp 3 )–H acyloxylation of indolin-3-ones with carboxylic acids catalysed by KI (2020 · Green Chemistry · 被引 27)
• A Novel Adamantane-Dioxetane-Based Chemiluminescent Probe for Highly Selective and Sensitive Bioimaging of Hydrogen Peroxide In Vitro and In Vivo (2025 · Analytical Chemistry · 被引 14)
• A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapy (2025 · Molecular Therapy · 被引 14)